佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

楼主: 软趴趴

CTIC 第二贴。

[复制链接]
发表于 7-10-2009 11:16 PM | 显示全部楼层
最近大股东出了不少货了

公司最近的內部交易記錄
日期名字/職位類型股數價格
2009/9/25BIANCO JAMES A
Director, CEO
賣出
318621
1.1918
2009/9/25BIANCO LOUIS A
EVP, Finance & Administration
賣出
105580
1.2302
2009/9/25Eramian Daniel G
EVP, Corporate Communications
賣出
104276
1.25
2009/9/25PHILIPS CRAIG
President
賣出
211500
1.2409
2009/9/25SINGER JACK W
Director, EVP, Chief Medical Officer
賣出
101380
1.2302
2009/9/11BIANCO JAMES A
Director, CEO
賣出
1366108
1.43
2009/8/14NUDELMAN PHILLIP M PHD
Director
賣出
164000
1.57
2009/8/12LOVE RICHARD L
Director
賣出
70000
1.64
2009/8/10BAUER JOHN H
Director
賣出
80000
1.5
2009/6/2BAUER JOHN H
Director
賣出
25000
1.76
回复

使用道具 举报


ADVERTISEMENT

发表于 7-10-2009 11:16 PM | 显示全部楼层
原帖由 雨若情 于 7-10-2009 11:13 PM 发表
我下一站就去maldives
马来西亚有海边的地方都去完咯。
sinpadan真的很美。
喜欢看鱼看海的朋友一定要去沙巴走走。
pulau pangkok岛隔壁小岛有个个resort叫:pulau pangkok resort
的地方也要去去。不然 ...

刚生完就丢下小孩自己去玩?
回复

使用道具 举报

发表于 7-10-2009 11:20 PM | 显示全部楼层
今晚的CVM 。。。   這只是熱身而已。。。
接下來。。 還有後續。。。。
回复

使用道具 举报

发表于 7-10-2009 11:21 PM | 显示全部楼层

回复 464# napster 的帖子

我怀孕4个月都去普吉岛钓鱼。
我一年没去几次海边的地方。就会发神经。

我有点想进ctic。 你怎样看?
顺便说说,今天看了你的旧帖子。 很精彩。
回复

使用道具 举报

发表于 7-10-2009 11:25 PM | 显示全部楼层
原帖由 雨若情 于 7-10-2009 11:21 PM 发表
我怀孕4个月都去普吉岛钓鱼。
我一年没去几次海边的地方。就会发神经。

我有点想进ctic。 你怎样看?
顺便说说,今天看了你的旧帖子。 很精彩。

不是那个帖子,哪有那么多人弃马投美。。。
maldives 很贵的。你可以到我的blog 去看maldives 网站连接,有几个不错的游记分享。
叶芬也想去。你们可以相约一起去
回复

使用道具 举报

发表于 7-10-2009 11:26 PM | 显示全部楼层
avii几天前跌到1.51时有买过10000。。1.61就卖了。。没想到1.9了。。

有机会跌回会再买。。
回复

使用道具 举报

Follow Us
发表于 7-10-2009 11:32 PM | 显示全部楼层

回复 465# napster 的帖子

一个人1w马币够吗?
最近才买了房子 生了孩子。预算自己去1w
回复

使用道具 举报

发表于 8-10-2009 01:16 AM | 显示全部楼层
没什么消息。。。。volume 非常 高。。。。
各位 没信心。。。。
觉得太久。。。

想 套现出来的。。。。迟些再买的。。。
这是机会。。。?。
回复

使用道具 举报


ADVERTISEMENT

发表于 8-10-2009 09:02 AM | 显示全部楼层
Cell Therapeutics, Inc ( CTIC ) Support & Resistance Levels - 10/8/09

Resistance Levels: $1.19, $1.28, $1.31

Support Levels: $1.00, $0.97, $0.91, $0.87





Cell Therapeutics, Inc ( CTIC ) made a textbook technical reversal off the 200 day moving average today. The stock traded below $0.87 for a split second and then the short covering came in. CTIC then broke through $0.96 ( the high of the day ) and ripped back to the 10 day moving average on heavy volume. CTIC is trading up a bit in after hours so expect tomorrow to be another active day. Resistance continues to be located at the 10 day moving average which tomorrow will be around $1.17. A close over back over this level would be very bullish going forward. As always, I like pullbacks to the 200 day moving average again.


XXXXXXXXXXXXXXXXXXXXX


Cell Therapeutics, Inc. (CTIC) - CTIC hit the 200 day moving averagethis morning, bounced, and then broke through the high of the daylocated at $0.96. CTIC then rallied back near the $1.20 resistancearea. I continue to like pullbacks to the 200 day moving average. Iwould also buy a break up through $1.20 for a quick trade.

[ 本帖最后由 葉芬 于 8-10-2009 09:05 AM 编辑 ]
回复

使用道具 举报

发表于 8-10-2009 10:16 AM | 显示全部楼层
   一定会起回來的
回复

使用道具 举报

发表于 9-10-2009 03:21 AM | 显示全部楼层
原帖由 napster 于 7-10-2009 11:25 PM 发表

不是那个帖子,哪有那么多人弃马投美。。。
maldives 很贵的。你可以到我的blog 去看maldives 网站连接,有几个不错的游记分享。
叶芬也想去。你们可以相约一起去


11月头去langkawi,有好介绍吗?好像水上resort呀之类的。O(∩_∩)O谢谢

Maldives等我有100万时去。。
回复

使用道具 举报

发表于 13-10-2009 11:15 AM | 显示全部楼层
Cell Therapeutics, Inc. (CTIC) - CTIC looks poised to close over the 10 day moving average on Monday, located at $1.14. Rallies back to the 50 day moving average ( currently $1.44 ) should be sold.
回复

使用道具 举报

发表于 14-10-2009 12:40 PM | 显示全部楼层
Cell Therapeutics, Inc ( CTIC ) Support & Resistance Levels - 10/14/09

Resistance Levels: $1.20, $1.30, $1.57

Support Levels: $1.11, $1.08, $1.00, $0.89





Cell Therapeutics, Inc. (CTIC) closed right at the 10 day moving average on Tuesday, something worth watching tomorrow. In order for this recent rally to continue, CTIC must go higher and break through $1.20. Failure to hold the 10 day moving average could spark another sell off back to the 200 day moving average. If the 200 day moving average ( $0.89 ) is retested, I would be a buyer.
回复

使用道具 举报

发表于 15-10-2009 04:20 AM | 显示全部楼层
NEW YORK, Oct 14 (Reuters) - CIT Group Inc (CIT.N) is getting closer to finalizing the terms of a new loan that would give them an additional $3 billion to $6.5 billion, two sources familiar with the matter said on Wednesday.

The loan, being arranged by Bank of America, could be finalized as soon as this week, the sources said, declining to be identified because talks are private. One of the sources said the situation was still fluid and it could be delayed.

CIT would use most of the additional money, except about $500 million, to repay existing debt, the sources said.

The loan would work as a secured facility in case of a successful exchange offer by the lender, or a debtor-in-possession loan if CIT has to file for bankruptcy, one source said.

CIT spokesman Curt Ritter declined to comment.

http://www.reuters.com/article/a ... idUSWEN468220091014

要买快点买, 好消息来的
回复

使用道具 举报

发表于 15-10-2009 04:30 AM | 显示全部楼层
对不起,post错了   错把CIT当成CTIC。。。嘻嘻嘻嘻嘻

CTIC
Last Trade:        1.15
Change:        Up 0.03 (2.68%)
回复

使用道具 举报

发表于 15-10-2009 07:32 PM | 显示全部楼层
怎么有那么多那么天真的CTIC迷呢???
这根本就是只烂股,怎么还是有一大堆人在里面发梦呢
要期待一只烂股好过把这些心思花在一些贵点股的吧
回复

使用道具 举报


ADVERTISEMENT

发表于 19-10-2009 09:43 AM | 显示全部楼层
Cell Therapeutics, Inc. (CTIC) - I continue to watch CTIC closely. The stock has resistance at $1.20 and I would be a buyer when CTIC breaks up through that level.
回复

使用道具 举报

发表于 22-10-2009 06:08 PM | 显示全部楼层
Cell Therapeutics Says Pixantrone Studies Show High Rates Of Complete Remission In Relapsed/refractory Aggressive, Indo

Cell Therapeutics Says Pixantrone Studies Show High Rates Of Complete Remission In Relapsed/refractory
Aggressive, Indolent NHL Patients - Quick Facts

Thu Oct 22 02:07:00 2009
EDT
(RTTNews) - Cell Therapeutics, Inc. (CTIC) announced that Richard Van der Jagt of the Ottawa General

Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of the company's

pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission

in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma, or NHL, patients.

The company revealed 70% CR/CRu rate in a phase II trial in patients treated with pixantrone plus
FPD-R regimen in relapsed/refractory  indolent NHL. The company also announced 47% CR/CRu rate  in a
phase II trial in patients treated with CPOP regimen  for patients that failed CHOP regimen with relapsed/refractory

aggressive NHL. Cell Therapeutics further disclosed 35% CR rate in a phase III trial in patients treated

with pixantrone plus rituximab in relapsed/refractory indolent NHL.

For comments and feedback: contact editorial@rttnews.com
Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved

CTIC,

BREAKING_NEWS, US, CORPORATE_NEWS,

This content is for use with eSignal products by authorized persons only. Any reference; link, frame,
or other use of this material without the explicit permission of eSignal is prohibited.
回复

使用道具 举报

发表于 23-10-2009 03:47 PM | 显示全部楼层
23/10/09


Cell Therapeutics, Inc. (CTIC) - CTIC continues to hang around the 10 day moving average. The volume remains very light compared to the average over the past 5 months. I would be a buyer on a close over $1.20. $1.20 seems to be a heavy resistance level for CTIC.
回复

使用道具 举报

 楼主| 发表于 30-10-2009 10:14 AM | 显示全部楼层
po tie...........
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 6-10-2025 03:40 PM , Processed in 0.143004 second(s), 18 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表